NeuroCreate Competitors

BrainCo’s leadership draws on deep experience in neuroscience research and expertise in education to deliver entirely new applications of brainwave technology in the education, wellness, and research spaces. We’ve learned important lessons as we’ve grown from a small team in an apartment basement to over 100 employees in 4 offices around the world. Since 2015 we’ve been working on providing the best experience possible for our customers and we’re here to share our progress and innovations with you.

MindMaze is a global leader in digital neuro-therapeutics (DTx) solutions with a mission to accelerate the brain's ability to recover, learn and adapt. With over a decade of work at the intersection of neuroscience, bio-sensing, engineering, mixed reality and artificial intelligence, its healthcare division is addressing some of the most challenging problems in neurology, including stroke, Alzheimer disease and Parkinson disease, by creating the universal platform for brain health and recovery and unique digital therapeutic interventions. MindMaze's pioneering FDA cleared and CE marked neuro-digital therapeutics accelerate patients' recovery from many critical neurological conditions. Founded in 2012 by CEO Dr Tej Tadi, MindMaze is the first Swiss Unicorn with offices in Lausanne, Baltimore, London, Paris and Mumbai.

Neurotechnology is a developer of high-precision algorithms and software based on deep neural networks and other AI-related technologies. The company was launched in 1990 in Vilnius, Lithuania, with the key idea of leveraging neural network capabilities for various applications, such as biometric person identification, computer vision and artificial intelligence. The company's solutions and products have been used in more than 140 countries worldwide and in many national-scale projects for national ID, passports, elections, and border control, including India's Aadhaar program, general elections in Ghana and Liberia, voter deduplication for the Democratic Republic of the Congo and other projects that collectively process the biometric data of nearly two billion people.